THE DIFFERENTIATION PATHWAY OF T LYMPHOCYTES : EVIDENCE FOR TWO DIFFERENTIATED CELL TYPES by Matter, Alex
THE  DIFFERENTIATION  PATHWAY  OF  T  LYMPHOCYTES 
EVIDENCE FOR  Two  DIFFERENTIATED  CELL TYPES* 
BY ALEX MATTER~: 
(From the Institut d'Histologie  et d'lEmbryologie, Ecole de M~decine, 
Geneva, Switzerland) 
(Received for publication 2 April 1974) 
The  ultrastructure  of  thymus-derived  (T)  lymphocytes from mouse  spleen 
and lymph nodes has  been  described  in  a  previous  report  (1).  In  the present 
study, differentiation steps for T  lymphocytes have been established  by study- 
ing cellular  transformation  in  response  to  allogeneic  stimulation.  Two  experi- 
mental  models  have  been  used:  in  the  first  a  graft-vs.-host  (GVH) l  reaction 
was induced  by injecting  thymocytes or cortisone-resistant  (CR)  thymocytes 
into lethally irradiated  allogeneic hosts (2, 3). This gave a donor T-cell popula- 
tion  in  the  spleen  with  relatively  weak  cytotoxic activity  when  tested  in  the 
chromium release  assay against  tumor cells of the same H-2 specificity  as  the 
host  (4).  In the second, rejection of an  allogeneic tumor graft  (5)  produced T 
cells of very high  cytotoxic activity in  the peritoneal  cavity.  Morphologically 
there were two differentiated T-cell types, a  dark one mainly seen in the GVH 
reaction and  resembling  the  cell  described  earlier  (1),  and  a  pale  one,  very 
frequent  during  tumor  graft  rejection.  Circumstantial  evidence  suggests  that 
this latter is the cytotoxic T  cell. 
Materials and Methods 
Animals.--CBA/J  (H-2k), C57/BL6  (H-2b), DBA/2 (H-2d), CDH (H-2k), Balb/c  (H-2  a) 
mice were obtained from C.S.E.A.L., Centre National  de la Recherche Scientifique, OrlEans- 
ta-Source, France, and Bomholtgard, Ry, Denmark. 
Tumor Cell Lines.--RBL-3,  a  C57/BL6  lymphoma  (kindly  donated  by Dr.  M.  Potter, 
N.I.H., Bethesda,  Md.), and P-815, a DBA/2 mastocytoma  (kindly donated  by Dr. K. T. 
Brunner,  I.S.R.E.C., Lausanne, Switzerland), were used. 
Antisera.--Rabbit  anti-mouse-specific lymphocyte  antigen  (aMSLA),  rabbit  antimouse 
Ig (RaMIg), mouse anti-~-CsH, and sheep antirabbit Ig (SaRIg) coupled to rhodamine (rho) 
or to horseradish peroxidase (pox) were prepared as described previously  (6). Alloantisera of 
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C57/BL6 anti-DBA/2 and of DBA/2 anti-C57/BL6 were obtained by repeated intraperitoneal 
injections of allogeneic spleen cells until strong cytotoxic titers were obtained. 
Cytotoxicity Tests.--Complement-dependent  cytotoxicity was determined  by trypan  blue 
dye exclusion (7) using agarose-absorbed rabbit serum  (8) as the source of complement (C). 
Preparation of Hydrocortisone-Resistant (CR) Thymocytes.--6-wk  old C57 and A mice were 
injected with 3 mg of hydrocorfisone succinate (Solu-Cortef, Upjohn Co., Kalamazoo, Mich.) 
according to Blomgren and Andersson (2) and killed 48 h later, 1 h after intraperitoneal injec- 
tion of indian ink to facilitate removal of the smallest thymus-adherent lymph nodes. 
Stimulation  of Thymocytes in  a GVH  Reaction.--DBA/2  mice were  lethally  irradiated 
(850 R) and injected intravenously with 100 X  l0  s thymocytes (or 10-20  X  106 CR-resistant 
thymocytes), according to the protocol of Cerottini et al.,  (4). 3-6 days later,  the mice were 
killed and their spleen cells used  (these mice seldom survive more than 5-6 days). 
Isolation of T Lymphocytes Cytotoxic for Allogeneic Tumor Cdls.--The protocol of Berke 
et al.,  (5) was  used  with  minor modifications.  10-15  X  l0  s RBL-3 (H-2 ~) or  P-815  (H-g  a) 
tumor  cells were injected  intraperitoneally into  adult  mice of a  different H-2  locus.  The 
recipient mice were killed 7-14 days later, 30 min after an intraperitoneal injection of indian 
ink.  The cells harvested from their peritoneal cavity were mainly lymphocytes and  macro- 
phages  (easily identified by the ingested carbon),  the tumor cells were usually dead  by  10 
days.  The  lymphocytes were purified  by  removal of  the  adherent  cells either  by passage 
through glass bead columns (Superbrite, type 100-5,005,  3M Co., St. Paul, Minn.) according 
to Rosenthal et al., (9), or by three successive incubations of 30 rain at 37°C in plastic culture 
dishes (Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) on a rocking platform (3 cpm), the 
cells  being suspended  in  medium  RPMI  1640 (Microbiological Associates Inc.,  Bethesda, 
Md.)  containing 6% fetal calf serum  (Flow Laboratories,  Irvine, Ayrshire, Scotland).  The 
final cell suspensions  contained 90-95% lymphocytes. The cytotoxicity of these lymphocytes 
was  determined  using  51Cr-labeled  tumor  ceils according  to  the  protocol of Cerottini and 
Brunner  (10). 
Fractionation  of  Nonadherent Cytotoxic  T  Lymphocytes.--Nonadherent  peritoneal  cells 
were fractionated either on Sephadex G-200 (Pharmacia Fine Chemicals AB, Uppsala, Sweden) 
linked  with rabbit  antimouse  Fab,  antibody  (11),  or  on  Degalan  (Degalan  V26,  Degussa 
Wolfgang AG, Hanau  am  Main,  Germany)  columns carrying complexes of mouse  Ig and 
rabbit antimouse Ig (12). 
Phase  Contrast Microcinematography of Living Cdls.--The  ceils,  suspended  in  culture 
medium containing 10% fetal calf serum, were introduced into a transparent perfusion cham- 
ber on a phase contrast microscope (Zeiss Universal, Oberkochen, West Germany) placed in a 
plexiglass incubator maintaining a  temperature of 37°C. 
Processing of Cells  for Immunofluorescence and Electron Microscopy.--Processing occurred 
as previously described (1, 6). For processing small numbers of cells for electron microscopy, 
plastic  capsules  were  used  (BEEM,  LKB  Produkter  AG,  Stockholm,  Sweden),  the  pellet 
being centrifuged at 150 g after each step. 
RESULTS 
The morphology of the different cell types that  were encountered  in cell sus- 
pensions of normal and cortisone-treated thymus will be dealt with in a separate 
report  (A. Matter,  manuscript  in preparation).  It shall suffice here to say that 
the cell types present  after allogeneic stimulation  were not seen  among thymo- 
cytes nor  CR-thymocytes.  This was  also true for mice injected with syngeneic 
thymocytes. The spleens of these latter animals yielded only small lymphocytes 
with a  pale "empty"  cytoplasm, plasma cells, macrophages,  and neutrophils. 
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TABLE I 
GVH Reaction Induced with Allogeneic Cells in Lethally Irradiated Hosts 
(Controls: Syngeneic Cells) 
Hosts*  Injected with:  killed  Day  Total  no.  Average  cells  no. of  Average of 
of exp.  recovered/spleen  host cells:[: 
% 
DBA/2  8 X  107 DBA/2 thymocytes  4  1  0.6 N  106  ND 
C57  8 X  107 C57 thymocytes  4  1  0.75 ×  106  ND 
DBA/2  10 s C57 thymocytes  3  2  107  10 
DBA/2  l0 s C57 thymocytes or 2 X  107  4  6  5 N  106  19 
CR-thymocytes§ 
DBA/2  l0 s C57 thymocytes or 2 X  107  5  5  1.5 X  106  30 
CR-thymocytes§ 
DBA/2  10 s C57 thymocytes  6  1  106  30 
* Irradiated  850 rad, groups of 10 animals. 
J/Host cells identified with alloantibodies produced in the donor strain  (C57), used either 
in cytotoxicity tests  (9) with Agar-absorbed rabbit complement (10) or in fluorescence with 
a sandwich technique (less than I% of cells stained directly with RaMIG-F1 because of sur- 
face Ig, so Ramig-F1 could be used to detect alloantibodies). 
§ See Material  and Methods  section. 
proliferation  that occurs in the spleen of lethally irradiated  mice injected  with 
allogeneic  cells.  Spleen  weights  at  day 4  were  increased  2-3  times  over non- 
injected lethally irradiated  controls. 
Spleen cell suspensions were prepared 3-6 days after allogeneic cell injection 
and the ultrastructure  of the donor cells examined. Though all stages of transi- 
tions occurred donor cells were classified  arbitrarily  into three  categories: 
(a)  Blast cells:  These  huge  cells  contained  considerable  numbers  of poly- 
ribosomes,  often  in  a  "rosette"  configuration,  usually  some profiles  of rough 
endoplasmic reticuhlm,  and sometimes one or several dense granules.  These T 
blasts  were identical  in  all  respects  to  the  T  blasts  observed in  the  spleen  or 
lymph nodes of normal mice immunized with various antigens. These cells were 
dividing very rapidly. If the spleens were fixed in situ at day 4 after grafting, 1 
h  after  colchicine  treatment  (300  #g  i.p.),  mitotic  figures  could  be  seen  in 
roughly 1 out of every 10-20 cells. 
(b)  Big dark cells:  Big dark cells were smaller than blasts and of strikingly 
dark appearance due  to large accumulations of closely packed monoribosomes 
and homogeneously greyish, usually peripheral,  areas of the cytoplasmic matrix 
(Fig.  1).  At high magnification these  areas  are seen  to consist of a  dense fila- 
mentous  network  (FN)  (inset,  Fig.  1).  Usually  these  cells  also  had  several 
elongated profiles of endoplasmic reticulum,  a  Golgi area mainly consisting of 
irregularly distributed flattened vesicles, granules,  and autophagosomes. 
(c)  Small dark cells:  This cell differed from the dark big cell mainly in its 
size (slightly bigger than a small  thymocyte but much smaller than a big dark ALEX~TTER  569 
Fie.  1.  Donor lymphocyte from the spleen of irradiated DBA/2 mice on day 5 after C57 
B1 thymocyte injection.  This cell type, classified as a big, dark cell, contains a vast number 
of monoribosomes, several ER profiles, and irregularly shaped vesicles. The mostly peripheral 
greyish zones (*) are illustrated at higher magnification in the inset: these zones have a fibrillar 
aspect closely resembling a filamentous network. 
cell)  and  in  its reduced content  of the  cytoplasmic constituents found in  the 
big dark cells (Fig. 2). 
Microcinematography.--Lymphocytes obtained from  the spleen 5  days after 
thymocyte injection flatten out very rapidly on glass surfaces and are extremely 
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Fro.  2.  Donor lymphocyte from the spleen of irradiated  DBA/2 mice on day 5 after C57 
BI thymocyte injection. This ceil is a representative of the small, dark cells containing Golgi 
complex, ER and also autophagosomes (*) and myelinic figures  (arrows). 
All the cells described above were shown to be T  cells originating from the 
injected thymocytes by the following experiments: (a) They all carried MSLA 
as shown by incubation in rabbit anti MSLA followed by SaRIg-pox. The cells 
were not stained when aMSLA was replaced by normal rabbit serum. (b) They 
survived incubation  with  anti  DBA/2  alloantiserum  plus  C,  this  killed  the 
residual host cells.  (c) They fixed anti-C57 but not anti-DBA/2 alloantibodies. 
The alloantibodies were demonstrated by incubation with RaMIg followed by 
SaRIg-pox. Since none of these cells carried detectable surface mouse Ig they 
did not stain directly with RaMIg followed by SaRIg-pox. 
The frequencies of  these  three cell  types were determined by counting at 
least 100 cells on days 3-5  (Fig. 3). There was a peak of blast cells at day 3, a 
peak of big, dark cells at day 5,  and a peak of small dark cells  at day 5. This 
sequence strongly suggests a  differentiation of donor T  cells during the  GVH 
reaction, from a  precursor thymocyte to a  blast  cell,  and then to  a  big dark 
and  possibly  to  a  small  dark  cell.  It  would  also mean  that  the  cytoplasmic O  BLASTS 
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FIG. 3.  Counts of donor cell types during the GVH reaction. Number of experiments in 
parentheses. For interpretation see text. 
features of dark ceils such as the Golgi  apparatus,  the FN,  the granules and 
the lysosomes are acquired during this period, and it seems logical to assume 
that these differentiation products are linked to the effector role of GVH cells. 
In chromium release assays with labeled Mastocytoma P-815 cells as targets, 
these cells were only weakly cytotoxic, in keeping with the results of Cerottini 
et al.,  (4). Ratios of killer to targets of 10:1 produced up to 40% lysis after 8 h 
of incubation, in other experiments lyric activity was minimal. 
Purification of Cytotoxic  T Lymphocytes  after In  Vivo Rejection  of Allogeneic 
Tumour Cells, and Study of Their Interactions with Their Targets.--Using minor 
modifications of the protocol of Berke, Sullivan, and Amos (5)  cells were col- 
lected from the peritoneal cavity of mice injected intraperitoneally 10-14  days 
earlier with allogeneic tumor cells. After removal of the glass-adherent peritoneal 
cells the population (recovery: 30-50 %) was almost exclusively T lymphocytes 
(more than 95 % in some experiments), as judged by rabbit aMSLA followed 
by SaRIg-rho for immunofluorescence, and by SaRIg,  pox for electron micros- 
copy  (EM).  Remaining macrophages  were  easily recognizable because  they 
contained large amounts of indian ink.  Granulocytes made up 5-10%  of the 
purified population. A few residual degenerating tumor cells of very large size 
were occasionally observed.  The purified population of T  lymphocytes were 
highly cytotoxic when mixed for 2 h  with fresh tumor cells labeled with 5tCr 
(50 % lysis at ratios of 1 : 1 killer to target cells). This cytotoxicity was entirely 
suppressed by pretreatment with mouse anti-0-C3H or rabbit aMSLA plus C. 
On  passage  of  cytotoxic, nonadherent  cells  through  columns of Sephadex 
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of the lytic activity was lost. Both losses  are considered to be unspecific, since 
fractionation on Sephadex alone gave practically the same losses. Fractionation 
on Degalan  carrying antigen-antibody complexes (12)  resulted in  a  far more 
serious loss.  The cell  number was decreased by about 50%  and  the lyric ac- 
tivity of the effluent cells by about 80 %. Since Degalan columns coated with 
normal mouse serum  took between 30  and 35 %  of the cells,  the specific loss 
was  15-20 %. All lymphocyte-like cell types (see below) were recovered in the 
effluent. The loss in lyric activity might be associated with the mitochondrial 
swelling which was very conspicuous in the case of Degalan-fractionated cells. 
It is concluded from these column experiments that cells carrying surface im- 
munoglobulins  or  Fc receptor sites  do  not  represent  a  numerically or  func- 
tionally important part  at  this  stage  of the  tumor graft rejection.  Since the 
origin of the effector cell population in this system is uncertain it was essential 
that the surface markers used to identify the cells  should be reliable.  Several 
additional controls were carried out to ascertain the specificity of the aMSLA: 
(a)  Normal  spleen  cells  treated  with  anti-0  and  C,  and  subsequently  with 
aMSLA and SaRIg-pox, were not labeled.  (b) The cell population elicited by 
proteose-peptone (1 ml 10% i.p., 72 h before sacrifice) was rich in macrophages 
and monocytes (--~50 %) but did not contain more than 3 % cells positive with 
aMSLA  as detected by immunofluorescence. In EM  aMSLA  and  SaRIg-pox 
gave only faint background labeling of the same cells.  (c) The cell suspensions 
always had  a  few remaining macrophages  and  granulocytes. These were not 
stained by a MSLA followed by SaRIg-pox. Therefore, aMSLA is considered a 
reliable and specific T-cell marker. 
Ultrastructure  of Cytotoxic  T  lymphocytes.--Cytotoxic  T  lymphocytes from 
the peritoneal cavity may be divided into two classes: dark cells and pale cells. 
They are similar in size,  about equivalent to a medium-sized lymphocyte, and 
neither phagocytoses carbon particles. 
The dark cell:  This cell is rich in monoribosomes, has a peripheral dense FN, 
a variously developed Golgi apparatus,  a few short profiles of ER, one or two 
granules, and an occasional autophagosome. These cells were not seen attached 
(0/25) to target cells after incubation in a chromium release assay and staining 
with aMSLA and SaRIg-pox. Their frequency declined rapidly after rejection 
of the  tumor. They accounted for 25 %  of aMSLA plus cells on day 10,  but 
only for 7 % on day 12 and 3 % on day 14 (one experiment for each time point). 
By day 14 there were often signs of cell degeneration. The similarity of these 
dark cells  with some of the GVH cells is quite striking.  Since the killing effi- 
ciency of purified peritoneal cells declined hardly at all  over this time period 
(A.  Matter  add  B.  A.  Askonas,  unpublished  observations)  the dark cells are 
presumably not the main cytotoxic T  cell. 
The  pale  cell (Fig.  4):  The  differences between  dark  and  pale  cells  are 
quantitative, not qualitative: the pale cell has less ribosomes, less ER, and less 
granules, but a more developed Golgi, more autophagosomes, bigger vacuoles, FIG.  4.  Cell  found in  the peritoneal cavity  at  the height  (day  10-12)  of  an  allogeneic 
tumor rejection (RBL-3 of C57 BI  origin in CBA or C3H  mice). Pale cells of this type form 
the large majority of cytotoxic T  lymphocytes at the height (day 10-12) of allogeneic tumor 
rejection. They do not possess a  lot of ribosomes but have many vesicles, granules,  multi- 
vesicular bodies, autophagosomes, vacuoles, and occasionally fat droplets. 
Fro.  5.  Pale T  cell (surface labeling with aMSLA and  SaRIg-pox) found  after incubation 
with fresh RBL-3 cells to be attached to a tumor cell. The latter has many microvilli. 
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and more microvesicles, often of the coated type. There are often one or two 
fat  droplets.  Curiously,  the  mitochondrial matrix is  usually much  denser in 
pale cells.  Microtubules are frequent, as well as fibrils of 80-100 ~  diameter. 
The FN  is  a  constant feature and well developed. At high  magnifications it 
seems to be less densely packed than in GVH cells;  it is therefore more easily 
resolved as a meshwork of filaments. This network seems to be linked to the 
100 .~ fibrils as well as to the microtubules. Pale cells are often seen attached 
to target cells when fixed in situ in the conditions of the chromium release assay 
(Fig.  5).  Microcinematography  shows  that  attachment  precedes  target  cell 
destruction; therefore pale cells seem to be the cytotoxic T  cells.  However, at- 
tachment does occur, though less frequently, with tumor cells other than those 
used  for sensitization.  The ultrastructural  characteristics  of  the  attachment 
and the events leading to target cell destruction will be dealt with in a separate 
report (A. Matter, manuscript in preparation). 
DISCUSSION 
The two systems used to study T-cell differentiation resulted in two func- 
tionally  different  cell  populations--the  GVH  reaction  induced  only  limited 
lyric activity, tumor graft rejection induced an  enormously efficient T-killed 
cell population. During GVH reaction in the conditions used in these experi- 
ments thymocytes differentiated into rapidly dividing blast  cells,  and further 
into big dark and, possibly, into small dark cells. This differentiation took place 
within about 5 days and resulted in a surprisingly homogeneous cell population. 
The tumor graft rejection did not show cell differentiation from a known start- 
ing population, but after rejection there was a functionally and morphologically 
very well defined T-cell population. This population comprises two cell types: 
a small number of relatively dark cells resembling the GVH cells,  and a ma- 
jority of pale cells.  Circumstantial evidence indicating that these pale cells are 
the killer cells can be summarized as follows: (a)  killing,  as measured by the 
chromium release assay, late in graft rejection is roughly equivalent to killing 
at the height of the rejection; the dark cells,  however, have practically disap- 
peared at this late stage;  (b) attachment, that is actual contact of killer cells 
with  target cells,  is important for killing  as demonstrated by our time-lapse 
study (unpublished observations) and by other investigators as well.  aMSLA 
plus cells seen attached to target cells after incubation in the conditions of the 
chromium release test are exclusively of the pale type. 
Therefore there seem to be two varifies of differentiated T cells:  a dark GVH 
cell and a pale killer cell.  This finding recalls recent evidence which seems to 
indicate that there are at least two peripheral T  cells,  T1 and T~, differing in 
their life span, homing pattern, surface antigens, sensitivity to drugs, X-rays, 
and mitogens (reviewed in 13, 14,  15). 
Currently it is believed that T1 cells are the precursors of killer cellS, and 
respond to transplantation antigens which are determined by the K  and D  loci ALEX MATTER  575 
of the H-2 chromosome (16, 17). T8 cells, however, are thought to be precursors 
of "amplifier" cells in the GVH reaction. They respond to the gene products 
of one or several MLC loci on the H-2 chromosome (18,  19) or of the M-locus 
(20). Synergy between T~ and T~ cells has been demonstrated in vivo (21), and, 
more recently, in vitro, during generation of cytotoxic cells (22, 23, 24). Specific 
absorption experiments have made it possible to distinguish a slowly dividing 
killer cell population from a rapidly dividing MLC population (17). 
In the light of all these findings it is tempting to suggest that the pale killer 
cells seen late in tumor graft rejection are the progeny of TI cells,  while the 
dark cell seen during the GVH reaction may be mainly amplifier cells,  which 
are not cytotoxic directly. The small number of dark cells found at the height 
of tumor graft rejection might be amplifiers of the pale  killer cells.  Alterna- 
tively these dark cells might be precursors of the pale cells,  a possibility which 
cannot be ruled out  at  this moment.  In further experiments we shall  try to 
elucidate the role of the strikingly different cytoplasmic machinery of the two 
cell types. 
SUMMARY 
Two experimental models have been used to study T-cell differentiation. The 
first,  a  graft-vs.-host reaction, was induced by injecting thymocytes or corti- 
sone-resistant thymocytes into lethally irradiated allogeneic mice. The second 
was tumor graft rejection in allogeneic hosts. Ultrastructural studies at various 
time intervals revealed two differentiated T-cell types. One of these (the "pale" 
cell) is probably high cytotoxic as measured in the chromium-release assay, the 
other (the "dark" cell) may be an "amplifier" cell, helping in the differentiation 
of cytotoxic cells. 
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